Intrexon Corp. | Ownership
Companies that own Intrexon Corp.
The Vanguard Group, Inc.
5,981,289
4.37%
355,303
0%
06/30/2018
Iridian Asset Management LLC
5,394,046
3.94%
-1,132,658
0.76%
06/30/2018
Fidelity Management & Research Co.
4,984,077
3.64%
-297,575
0.01%
06/30/2018
Miller Value Partners LLC
4,767,125
3.48%
-42,875
2.46%
06/30/2018
SSgA Funds Management, Inc.
4,341,652
3.17%
543,896
0.01%
06/30/2018
BlackRock Fund Advisors
4,252,960
3.11%
1,763,068
0%
06/30/2018
First Trust Advisors LP
3,210,823
2.34%
-422,293
0.09%
06/30/2018
Morgan Stanley Investment Management, Inc.
2,405,208
1.76%
23,210
0.05%
06/30/2018
Northern Trust Investments, Inc.
925,865
0.68%
514,541
0%
06/30/2018
Barclays Capital, Inc.
780,119
0.56%
137,527
0.19%
06/30/2018
| Address |
20374 Seneca Meadows Parkway
Germantown Maryland 20876
United States
|
|
Employees
|
- |
| Website |
http://www.dna.com |
| Updated |
07/08/2019 |
| Intrexon Corp. is a biotechnology company, which engages in the business of synthetic biology. It focuses on on programming biological systems to alleviate disease, remediate environmental challenges, and provide sustainable food and industrial chemicals. The firm offers UltraVector, RheoSwitch, cell systems informatics, protein engineering, and antibody discovery. |
